Synergy CHC Q2 net income up 125% to $1.5M; completes $20M debt refinancing

Synergy CHC Corp.

2025-Q2 EPS reported $0.27 vs consensus $0.08 ▲ beat (+230.9%)

Revenue $8.1M (+1% YoY); gross margin expanded to 76.7% from 69.5% on license revenue.
Net income $1.5M (EPS $0.17) vs $655K ($0.09) YoY; EBITDA $3.80M vs $1.61M.
Tenth consecutive quarter of profitability; working capital surplus $12.4M vs deficit $1.12M at Dec 31.
Completed $20M term loan (drawn $17.5M) due May 2029; reduced liabilities $869K in Q2, $1.8M post-quarter.
International licensing for FOCUSfactor expanded to Turkey; retail distribution wins expected Q4 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.